TrialHepatology international2015

Preemptive adefovir versus lamivudine for prevention of hepatitis B reactivation in chronic hepatitis B patients undergoing chemotherapy.

Edith Y Ho et al.PubMed ↗Publisher ↗

No numbers read from the abstract.